Focus Stocks
IMAX Closing in to Resistance
Published on Thursday, 09 February 2012 07:28 Written by TradersHuddle Wire
New York, February 9th (TradersHuddle.com) - Shares of Imax Corporation (NASDAQ:IMAX) are trading very close to calculated resistance at $22.52 with the current price action closing at just $21.89 placing the stock near levels that make it difficult to buy.
Imax Corporation (NASDAQ:IMAX) specializes in motion picture technologies and large-format film presentations. The company designs and manufactures projection and sound systems for large-screen theaters and designs custom attractions, including motion simulation theaters, for both large-scale attractions and smaller venues.
IMAX's current stock range is defined by current calculated support defined at $20.29 and by the resistance level at $22.52, the stock is clearly over-extended from support, making it difficult to establishing new long positions at this level.
Traders don't have a clear entry point for IMAX, as the stock is well above support, however, as the stock pulls back towards $20.29 it will definitely provide a reference point to establish a trade. On the other hand if the stock decides to break above resistance level at $22.52 then traders will get an opportunity to enter IMAX stock by establishing a position as the stock moves to a higher range.
Related Articles
- Bulls and Bears on the Trenches of IMAX
- Bears Appeared on IMAX
- Key Levels for IMAX
- Trading Idea: Entry Levels for IMAX
- IMAX, Reversal Soon?
- IMAX is Near a Key Support Area
- IMAX Is Close to its 50 Day Moving Average
- Is IMAX Close to Support?
- Trading Idea: What to Expect as IMAX Breaks Resistance
- Trading Idea: - Is IMAX close to Resistance?
Related Partner Headlines
- UPDATE: Imax Posts In-Line Q4 Profit - Benzinga
- Imax Rises On Unusually High Volume (IMAX) - TheStreet.com
- IMAX Expands Relationship With China's Broadway Theatre Company With Four Theatre Deal - Benzinga
- IMAX Partners With Barco to Co-Develop Next-Generation Laser Projection Technology - Benzinga
- Why You Shouldn't Believe the Netflix/Verizon Deal Rumors - TheStreet.com
- Imax Shares Jump on Upgrade, CEO Presentation - TheStreet.com
- Imax Stock Hits New 52-Week Low (IMAX) - TheStreet.com
TradersHuddle Search
| Sponsored By: |
|
Stock Search: |
|
Site Search: Loading
|
Recent Trading Ideas
Latest Partner Headlines
-
The Dow Bounces on Test of 12,312 - TheStreet.com -
Coming Week: Top Nine Earnings on Deck - TheStreet.com -
For Ambitious Students, Entrepreneurship Can Be a Big Win - TheStreet.com -
Something's Not Right in the Video-Game Space - TheStreet.com -
Stock Futures Rise on Eurobond Talk - TheStreet.com -
You Can Let Your Guard Down: Ask Noah - TheStreet.com -
NYSE Is Winning the IPO Listing War - TheStreet.com -
Apple Strengthens Its Supply Chain - TheStreet.com
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:12,529.75 Trade time:4:05PM EDT Value change:▲33.60 (0.27%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,320.68 Trade time:4:32PM EDT Value change:▲1.82 (0.14%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:2,839.38 Trade time:5:16PM EDT Value change:▼10.74 (-0.38%)In The Wires
-
Vertex Receives European CHMP Positive Opinion for KALYDECO™ (ivacaftor), the First Medicine to Treat the Underlying Cause of Cystic Fibrosis -
SunOpta Enters Into Agreement to Divest Its Canadian Based Natural Health Products Business -
PC Connection, Inc. (PCCC) To Present at The SeeThruEquity First Annual Small Cap Investor Conference on Tuesday, June 5, 2012 -
Aeroflex Announces Amendment to Credit Agreement -
Alliance Data to Participate at Upcoming Investor Conferences -
PCA3 Test Featured at American Urological Association Meeting -
MOCON Announces Quarterly Dividend -
Government of Rwanda Introduces Merck's ROTATEQ® (Rotavirus Vaccine, Live, Oral, Pentavalent) to Help Protect Children Against Rotavirus









